DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: TYSABRI (natalizumab)
       *****************************************************
       #Post#: 2818--------------------------------------------------
       (Abst.) Duration of Tysabri therapy and reasons for discontinuat
       ion in an MS population
       By: agate Date: February 19, 2020, 7:26 pm
       ---------------------------------------------------------
       Cleveland Clinic researchers studied 554 patients with MS who
       started and stopped Tysabri.
       From PubMed (February 19, 2020)--"Duration of natalizumab
       therapy and reasons for discontinuation in a multiple sclerosis
       population":
  HTML https://www.ncbi.nlm.nih.gov/pubmed/32064117
       *****************************************************